Clinical experience
Clinical experience
Results
of the treatment of cutaneous vascular lesions by method of selective
laser coagulation with Yachroma-Med copper vapor laser
Part 1. | Part
2. | Part 3.
To
assess the result of the treatment of skin vascular lesions the next
criteria are used:
- Complete removing the pathology;
- Notable removing the pathology;
- More than 50% disappearance of abnormal vessels;
- Without changes.
Effectiveness of the treatment of facial telangiectasies
Diagram 1. Facial telangiectasia
|
Complete removing the pathology; |
|
Notable removing the pathology; |
|
More than 50% improvement |
|
Negligible improvement |
Now let see a diagram. 92% of
the patients with facial telangiectasia showed complete and notable
removing the pathologies. Only 3% of the patients ware resistant to
the treatment. Resistant patients had telangiectasia of nasal alae.
Note that 45% of the patients with facial telangiectasias have lesion
on the nose.
Diagram 2. Nasal telangiectasia
This diagram represents the results of the treatment
of nasal telangiectasias. Complete and notable removing the
pathologies achieved in 93% lesions.
The next diagram 3 show effectiveness
of
a nasal telangiectasia treatment.
Diagram 3. telangiectasia of nasal alae
Almost all the patients with facial
telangiectasia satisfied of the treatment results.
Effectiveness of the treatment of low extremity telangiectasies
Diagram 4.
|
Complete removing the pathology; |
|
Notable removing the pathology; |
|
More than 50% improvement |
|
Negligible improvement |
See please a
diagram representing the effectiveness of the treatment of leg
telangiectasias. Patients with venous telangiectasias which diameter
is less than 0.6 mm are revealed complete disappearance of the
pathology. Notable removing the pathology is achieved in 27 %
occurrences. 4% of the patients show more than 50% disappearance of
abnormal vessels and 4% show results assessed as without changes.
Laser coagulation is less effective in case of leg telangiectasias
which diameter is more than 0.6 mm. Sclerotherapy is applied to these
patients.
Part 1. | Part
2. | Part 3.
Back to the top
|